Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States Milena Sant a , Claudia Allemani a, *, Roberta De Angelis b , Antonino Carbone c , Silvia de SanJose ` d , Alessandro M. Gianni e , Pilar Giraldo f , Francesca Marchesi a , Rafael Marcos-Gragera g , Carmen Martos-Jime ´nez h , Marc Maynadie ´ i , Martine Raphael j , Franco Berrino a , EUROCARE-3 Working Group k a Department of Preventive and Predictive Medicine, Fondazione IRCCS ‘Istituto Nazionale dei Tumori’, Via Venezian 1, I-20133, Milan, Italy b Department of Cancer Epidemiology, National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita `, Rome, Italy c Pathology Department, Fondazione IRCCS ‘Istituto Nazionale dei Tumori’, Milan, Italy d Epidemiology and Cancer Registry, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain e Leukaemia and lymphoma Department, Fondazione IRCCS ‘Istituto Nazionale dei Tumori’, Milan, Italy f Department of Haematology, Hospital Universitario Miguel Servet, Zaragoza, Spain 0959-8049/$ - see front matter Ó 2008 Elsevier Ltd. All rights reserved. doi:10.1016/j.ejca.2007.12.016 * Corresponding author: Tel.: +39 02 23903521/2901/2; fax: +39 02 23903516. E-mail address: claudia.allemani@istitutotumori.mi.it (C. Allemani). k The EUROCARE-3 Working Group is: Austria: W. Oberaigner (Tyrol Cancer Registry); Denmark: H.H. Storm (Danish Cancer Society, Department of Cancer Prevention and Documentation); Estonia: T. Aareleid (Estonian Cancer Registry); Czech Republic: M. Jechova, M. Rousarova (IHIS and West Bohemia Cancer Registry); Finland: T. Hakulinen (Finnish Cancer Registry); France: G. He ´ delin (Bas-Rhin Cancer Registry), I. Tron, E. Le Gall (Bretagne Childhood Cancer Registry), G. Launoy (Calvados Digestive Cancer Registry), J. Mace ´ -Lesec’h (Calvados General Cancer Registry), J. Faivre (Co ˆ te d’Or Digestive Cancer Registry), G. Chaplain (Co ˆ te d’Or Gynaecologic Cancer Registry), P.-M. Carli (Co ˆte d’Or Malignant Haemopathies Registry), A. Danzon (Doubs Cancer Registry), B. Tretarre (He ´ rault Cancer Registry), M. Colonna (Ise `re Cancer Registry), B. Lacour (Lorraine Childhood Cancer Registry), N. Raverdy (Somme Cancer Registry), C. Berger, F. Freycon (Rho ˆne-Alpes Childhood Registry), P. Grosclaude (Tarn Cancer Registry), J. Este `ve (University of Lyon); Germany: P. Kaatsch (German Childhood Cancer Registry), H. Ziegler (Saarland Cancer Registry), D. Ho ¨ lzel, G. Schubert Fritschle (Munich Cancer Registry); Iceland: L. Tryggvadottir (Icelandic Cancer Registry); Italy: F. Berrino (Project Leader), C. Allemani, P. Baili, L. Ciccolallo, P. Crosignani, G. Gatta, A. Micheli, M. Sant, (Fondazione IRCCS ‘Istituto Nazionale dei Tumori’, Milan, Unit of Etiological Epidemiology and Prevention and Lombardy Cancer Registry, Varese Province) S. Ferretti (Ferrara Cancer Registry), E. Conti l , V. Ramazzotti (Istituto Nazionale Tumori ‘Regina Elena’, Rome, Latina Cancer Registry), M. Vercelli, A. Quaglia (Liguria Region Cancer Registry, DOBIG University GE, IST Genova), F. Pannelli (Macerata Cancer Registry, Marche Childhood Cancer Registry), M. Federico, M.E. Artioli (Modena Cancer Registry), M. Ponz De Leon, P. Benatti (Modena Colorectal Cancer Registry), V. De Lisi, L. Servente (Parma Cancer Registry), R. Zanetti, S. Patriarca (Piedmont Cancer Registry), C. Magnani, G. Pastore (Piedmont Childhood Cancer Registry), L. Gafa `, R. Tumino (Ragusa Cancer Registry), F. Falcini (Romagna Cancer Registry), M. Budroni (Sassari Cancer Registry), E. Paci, E. Crocetti (Tuscan Cancer Registry), P. Zambon, S. Guzzinati (Venetian Cancer Registry), R. Capocaccia, E. Carrani, R. De Angelis, P. Roazzi, M. Santaquilani, A. Tavilla, F. Valente, A. Verdecchia (Istituto Superiore di Sanita `, Rome); Malta: M. Dalmas (Malta National Cancer Registry); Norway: F. Langmark, A. Andersen (Cancer Registry of Norway, Institute of Population-based Cancer Research); Poland: J. Rachtan (Cracow Cancer Registry), M. Bielska-Lasota, Z. Wronkowski (Warsaw Cancer Registry); Slovakia: I Ples ˇko, A Obsitnı´kova ´ (National Cancer Registry of Slovakia); Slovenia: V. Pompe-Kirn (Cancer Registry of Slovenia); Spain: I. Izarzugaza (Basque Country Cancer Registry), C. Martinez-Garcia (Granada Cancer Registry), I. Garau (Mallorca Cancer Registry), C. Navarro, M.D. Chirlaque (Murcia Cancer Registry), E. Ardanaz, C. Moreno (Navarra Cancer Registry), J. Galceran (Tarragona Cancer Registry), A. Torrella (Childhood Tumor Registry of Valencia), R. Peris-Bonet (National Childhood Cancer Registry and Instituto Lopez Pinero, Valencia); Sweden: L. Barlow, T. Mo ¨ ller (Cancer Registry of Sweden); Switzerland: G. Jundt (Basel Cancer Registry), J.M. Lutz, M. Usel (Geneva Cancer Registry); The Netherlands: J.W.W. Coebergh (Eindhoven Cancer Registry), A. van der Does-van den Berg (Dutch Childhood Oncology Group), O. Visser (Amsterdam Cancer Registry); UK, England: S. Godward (East Anglian Cancer Registry), M.P. Coleman (London School of Hygiene and Tropical Medicine), E.M.I. Williams (Merseyside and Cheshire Cancer Registry), D. Forman (Northern and Yorkshire Cancer Registry and Information Service), M.J. Quinn (Office for National Statistics), M. Roche, S. Edwards (Oxford Cancer Intelligence Unit), C. Stiller (Childhood Cancer Research Group, Oxford), J. Verne (South West Cancer Intelligence Services), H. Møller, J. Bell (Thames Cancer Registry), J.L. Botha (TrentCancer Registry), G. Lawrence (West Midlands Cancer Intelligence Unit); UK, Scotland: R. Black (Scottish Cancer Intelligence Unit); UK, Wales: J.A. Steward (Welsh Cancer Intelligence and Surveillance Unit). l Dr. Ettore Conti died on August 2, 2003. EUROPEAN JOURNAL OF CANCER 44 (2008) 579 – 587 available at www.sciencedirect.com journal homepage: www.ejconline.com